Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
Go back to Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis| (NASDAQ: KNSA) | Delayed: 55.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.11 | 52 Week High | $ | |||
| Open | $55.11 | 52 Week Low | $ | |||
| Day High | $55.11 | P/E | N/A | |||
| Day Low | $55.11 | EPS | $ | |||
| Volume | 9,423 | |||||

